; and (2) may, if the Board determines necessary, use the authorities granted the President under titles I and III of the Defense Production Act of 1950 ( 50 U.S.C. 4501 et seq.). (g) Funding The Board may, without further appropriation in fiscal years 2020 and 2021, obligate and expend such sums as are necessary, as determined by the Board, to carry out this section, except that the Board may obligate and expend not more than $75,000,000 in each of fiscal years 2020 and 2021, for administrative costs. 5. Guidance for State reopening plans (a) In general Not later than the date that is 2 weeks after the date of enactment of this Act, using the best available information, including information generated in implementing this Act, the Secretary shall issue guidance on the development of reopening plans that evaluates the efficiency of different safeguards and the capacity of different combinations of safeguards to meet the public health goals of such plans while maximizing social and economic reopening. (b) Updates Not less than every two weeks, the Secretary shall update such guidance as appropriate to reflect changes in knowledge and information. 6. Improved understanding of coronavirus testing and contribution to reopening plans (a) In general The Director of the Biomedical Advanced Research and Development Authority (in this section referred to as the Director ), in coordination with the Director of the Centers for Disease Control and Prevention, shall carry out an emergency program to evaluate on an expedited basis both the reliability of different tests and forms of testing and the capacity of those tests to contribute to reopening plans. (b) Program components This program under this section shall recognize the different practicalities to scale up different forms of tests, including self-administered and professionally administered tests, and shall include the following: (1) Evaluation of self-administered tests The Director shall institute, on an expedited basis, an evaluation of those promising